Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis

Br J Dermatol. 2023 Dec 20;190(1):132-134. doi: 10.1093/bjd/ljad389.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Biopsy
  • Eczema* / drug therapy
  • Humans
  • Machine Learning
  • Skin* / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab